Rare diseases
Investigational molecules
Locations
Paseo De Gracia 54 2d, 08007 Barcelona, Spain
Gyala Therapeutics S.L. focuses on acute leukemia research, with clinical activity in relapsed/refractory acute myeloid leukemia and relapsed/refractory T-cell acute lymphoblastic leukemia. Its work is centered on challenging blood cancers that require new treatment options after standard therapies have failed.
The sponsor’s clinical interest is directed toward high-risk hematologic disease in patients with limited therapeutic alternatives.
Gyala Therapeutics S.L. runs clinical trials in conditions such as T-cell type acute leukaemia, Acute myeloid leukaemia, Acute myeloid leukaemia refractory, among others.
Clinical trials run by this sponsor – those enrolling participants first.
SpainIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
